Eurasian Journal of Medical and Natural Sciences 4-jild 5-son (2024) · 153–161-betlar

EXPLORING THE ROLE OF MICRORNA-122 IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Парпибаева, Динора, Эргашов, Нодирбек

DOI: 10.5281/zenodo.11201818 · Manbada o'qish →

Annotatsiya

Non-alcoholic fatty liver disease (NAFLD) has become a significant public health problem worldwide, representing a spectrum of liver diseases from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma (HC). The global prevalence of NAFLD has reached epidemic proportions, closely paralleling the rising prevalence of obesity, insulin resistance, type 2 diabetes mellitus and metabolic syndrome.

Non-alcoholic fatty liver disease (NAFLD), microRNA-122 (miR-122), biomarkers.Неалкогольная жировая болезнь печени (НАЖБП), микроРНК-122 (miR-122), биомаркеры.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.